Status:
RECRUITING
Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases
Lead Sponsor:
Kuopio University Hospital
Conditions:
Alzheimer Disease
Frontotemporal Dementia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times...
Detailed Description
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times...
Eligibility Criteria
Inclusion
- Mild Cognitive Impairment due to Alzheimer's disease
- Dementia with Lewy Bodies
- Frontotemporal dementia
- Idiopathic normal pressure hydrocephalus (iNPH)
Exclusion
- History of seizures
- Pregnancy
- Metal implants in the head (except dental fillings)
- Electronic implants (i.e. pace-maker, implanted medical pump)
- Age \<18 years
Key Trial Info
Start Date :
November 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2032
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05326750
Start Date
November 21 2022
End Date
July 1 2032
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kuopio University Hospital
Kuopio, Finland